相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Current and upcoming therapies to modulate skin scarring and fibrosis
Joao Q. Coentro et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Smad7 Ameliorates TGF-β-Mediated Skin Inflammation and Associated Wound Healing Defects but Not Susceptibility to Experimental Skin Carcinogenesis
Fulun Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions
Saeid Amini-Nik et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5
Erfei Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Pentoxifylline inhibits angiogenesis via decreasing Dll4 and Notch1 expression in mouse proepicardial explant cultures
Justyna Niderla-Bielinska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study
Erfei Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study
Erfei Chen et al.
MOLECULAR CANCER (2018)
Pleiotropic FTY720 Is a Specific and Potent Therapy for Hypertrophic Scars
Fen Shi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Inhibition of FKBP10 Attenuates Hypertrophic Scarring through Suppressing Fibroblast Activity and Extracellular Matrix Deposition
Xiao Liang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Impaired wound healing in bleomycin-induced murine scleroderma: a new model of wound retardation
Tatsuo Maeda et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
SIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation
Ganye Zhao et al.
AGING-US (2016)
Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars
Xiao-Zhi Bai et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Hypertrophic scarring: the greatest unmet challenge after burn injury
Celeste C. Finnerty et al.
LANCET (2016)
Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway
Xiaozhi Bai et al.
EXPERIMENTAL DERMATOLOGY (2015)
RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells
Jessica J. Mezzanotte et al.
EPIGENETICS (2014)
A Novel Murine Model of Hypertrophic Scarring Using Subcutaneous Infusion of Bleomycin
Alexander M. Cameron et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Pentoxifylline improves cutaneous wound healing in streptozotocin-induced diabetic rats
Saeed Babaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Potentiation of Anticancer Drugs: Effects of Pentoxifylline on Neoplastic Cells
Miroslav Barancik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Potential New Therapeutic Agents for Diabetic Kidney Disease
Faruk Turgut et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Intralesional pentoxifylline as an adjuvant treatment for perioral post-burn hypertrophic scars
Cesar Isaac et al.
BURNS (2010)
Pentoxifylline modifies three-dimensional collagen lattice model contraction and expression of collagen types I and III by human fibroblasts derived from post-burn hypertrophic scars and from normal skin
Cesar Isaac et al.
BURNS (2009)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
The emerging role of FOXO transcription factors in pancreatic β cells
Dominique A. Glauser et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Pentoxifylline inhibits mature burn scar fibroblasts in culture
JM Rawlins et al.
BURNS (2006)